Imbrium Therapeutics Announces First Patient Dosed in Phase 2 Study of Potential First-in-Class Molecule for Insomnia Associated with Alcohol Cessation - Valdosta Daily Times

Submitted by Anonymous (not verified) on Wed, 10/16/2019 - 12:31

Imbrium Therapeutics Announces First Patient Dosed in Phase 2 Study of Potential First-in-Class Molecule for Insomnia Associated with Alcohol Cessation  Valdosta Daily Times